{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-033017","form_type":"8-K","ticker":"ICCC","cik":"0000811641","company_name":"IMMUCELL CORP /DE/","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.238196+00:00","generated_at":"2026-05-17T00:46:37.569980+00:00","sec_items":["5.02","9.01","2.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ImmuCell names Olivier te Boekhorst CEO; board expanded to nine directors","bullets":["Olivier te Boekhorst started as President and CEO on Nov 1, 2025, succeeding Michael Brigham.","Board expanded from 7 to 9 directors; te Boekhorst and CFO Timothy Fiori elected as directors.","Michael Brigham remains board member and Special Advisor to CEO until January 2026.","CFO Fiori also appointed Secretary and Treasurer.","Company to host Q3 earnings conference call on Nov 14, 2025 at 9:00 AM ET."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-033017","json":"https://secwatch.observer/filing/0001437749-25-033017.json","markdown":"https://secwatch.observer/filing/0001437749-25-033017.md","text":"https://secwatch.observer/filing/0001437749-25-033017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/811641/000143774925033017/0001437749-25-033017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811641/000143774925033017/iccc20251103_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:46:37.569980+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}